Audit 176613

FY End
2022-12-31
Total Expended
$43.04M
Findings
4
Programs
14
Organization: Kettering Health Network (OH)
Year: 2022 Accepted: 2023-09-10
Auditor: Ernst and Young

Organization Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
TSM1EPFQ6R88 Gregory Rosengarten Auditee
5137621612 Joe Muraca Auditor
No contacts on file

Notes to SEFA

Title: Federal Direct Student Loans Accounting Policies: The schedule of expenditures of federal awards includes the federal grant activity of Kettering Health (the System) and is presented using the accrual basis of accounting. The information in the schedule of expenditures of federal awards is presented in accordance with requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). De Minimis Rate Used: N Rate Explanation: The System did not elect to utilize the 10% de minimis indirect cost rate allowed by the Uniform Guidance. The System acts as an intermediary for students receiving Federal Direct Student Loans (Assistance Listing No. 84.268) (which includes the Direct Stafford Loan and Direct PLUS Loan Programs) from the federal government. The federal government is responsible for the billing and collection programs of the loans. The System assists the federal government by processing the applications and applying funds to student accounts from the federal government. Since the program is administered by the federal government, new loans made in the year ended December 31, 2022, related to Federal Direct Student Loans and Federal Direct Student Loans Graduate are considered current year federal expenditures, whereas the outstanding loan balances are not. The new loans made during the year ended December 31, 2022, totaled $8,264,825 for Federal Direct Student Loans and $3,169,875 for Federal Direct Student Loans Graduate, as reflected on the schedule of expenditures of federal awards.
Title: Nursing Student Loans Accounting Policies: The schedule of expenditures of federal awards includes the federal grant activity of Kettering Health (the System) and is presented using the accrual basis of accounting. The information in the schedule of expenditures of federal awards is presented in accordance with requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). De Minimis Rate Used: N Rate Explanation: The System did not elect to utilize the 10% de minimis indirect cost rate allowed by the Uniform Guidance. The System administers the Nursing Student Loans program (Assistance Listing 93.364) and the Federal Perkins Loan Program (Assistance Listing 84.038). The following information details the amounts shown per the schedule of expenditures of federal awards and the outstanding loan balances at December 31, 2022: Nursing Student Loans Outstanding balance as of January 1, 2022: $ 107,452 2022 advances: Administrative allowance Amount of expenditures per the schedule of expenditures of federal awards: $ 107,452 Outstanding balance as of December 31, 2022 $ 98,539 Federal Perkins Loan Program Outstanding balance as of January 1, 2022: $ 98,459 2022 advances: Administrative allowance: Amount of expenditures per the schedule of expenditures of federal awards: $ 98,459 Outstanding balance as of December 31, 2022: $ 35,317
Title: Covid-19 Provider Relief Fund (PRF) and American Rescue Plan (ARP) Accounting Policies: The schedule of expenditures of federal awards includes the federal grant activity of Kettering Health (the System) and is presented using the accrual basis of accounting. The information in the schedule of expenditures of federal awards is presented in accordance with requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). De Minimis Rate Used: N Rate Explanation: The System did not elect to utilize the 10% de minimis indirect cost rate allowed by the Uniform Guidance. The schedule of expenditures of federal awards includes $27,741,256 received from the U.S. Department of Health and Human Services (HHS) between April 10, 2020 and March 31, 2022, under the COVID-19 Provider Relief Fund (PRF) Assistance Listing No. 93.498. In accordance with guidance from HHS, these amounts are presented as Period 3 and Period 4 in the HHS PRF Reporting Portal. Such amounts were recognized as other revenue in the Systems consolidated financial statements in the consolidated statements of operations and changes in net assets for the years ended December 31, 2022 and 2021. Due to the PRF Reporting Portal requirements, the amount on the schedule of expenditures of federal awards is not the total PRF received and/or recognized by the System as other revenue in the Systems consolidated financial statements for the year ended December 31, 2022

Finding Details

Finding 2022-001 ? A. Activities Allowed or Unallowed, B. Allowable Costs / Cost Principles, E. Eligibility, and N. Special Tests and Provisions ? Material Weakness in Internal Controls Over Compliance Identification of the federal program: Assistance Listing 93.461 ? COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured (U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA) (HRSA COVID-19 Uninsured Program) Criteria or specific requirement (including statutory, regulatory or other citation): Section 200.303 of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), states the following regarding internal control: ?The non-federal entity must: establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statues, regulations, and the terms and conditions of the federal award. These internal controls should be in compliance with guidance in Standards for Internal Control in the Federal Government (also known as the Green Book) issued by the Comptroller General of the United States or the Internal Control ? Integrated Framework (COSO Framework) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).? Kettering Health Schedule of Findings and Questioned Costs (continued) 2307-4310198 70 Section III ? Federal Award Findings and Questioned Costs (continued) Health and Human Services (HHS) ? (HRSA issued Terms and Conditions for Participation in the HRSA COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured Program (T&Cs) outlining requirements that recipients of funding from the HRSA COVID-19 Uninsured Program must comply with including the following sections: Testing Services, Treatment Services and Vaccine Administration, and General Provisions in FY2020 Consolidated Appropriations. Condition: The System did not appropriately design or implement internal controls over the HRSA COVID-19 Uninsured Program T&Cs as of and for the year ended December 31, 2022. Cause: Though there are internal controls in place with respect to the System?s revenue cycle, the System did not specifically have internal controls in place to ensure compliance with the HRSA COVID-19 Uninsured Program T&Cs. Effect or potential effect: If adequate internal controls are not designed and implemented, the System may not be in compliance with the HRSA COVID-19 Uninsured Program T&Cs, or the System may not take necessary actions required to comply with the HRSA COVID-19 Uninsured Program related to Uniform Guidance compliance requirements A. Activities Allowed or Unallowed, B. Allowable Costs/Cost Principles, E. Eligibility, and N. Special Tests and Provisions Questioned costs: None. Kettering Health Schedule of Findings and Questioned Costs (continued) 2307-4310198 71 Section III ? Federal Award Findings and Questioned Costs (continued) Context: The HRSA COVID-19 Uninsured Program had federal expenditures of $1,105,658 for the year ended December 31, 2022 and was determined to be Type A major federal program. Identification as a repeat finding, if applicable: This is a repeat finding. The prior year finding reference is Finding 2021-001. Recommendation: Due to the nature of this program and the timing of the finding identified in the prior year, the System did not have the opportunity to remediate the prior year finding. While this program likely will not exist in future periods, the System should implement internal controls to document its review and compliance with future federal program T&Cs and the Uniform Guidance and ensure appropriate documentation is retained to support the operating effectiveness of the implemented internal controls. Views of responsible officials: Management agrees with the finding and has developed a plan to address the finding and will ensure appropriate internal controls and documentation are in place for future programs.
Finding 2022-002 ? A. Activities Allowed or Unallowed and B. Allowable Costs / Cost Principles ? Material Weakness in Internal Controls Over Compliance Identification of the federal program: Assistance Listing 93.498 ? COVID-19 Provider Relief Fund (PRF) and American Rescue Plan (ARP) Rural Distribution (PRF Program) Criteria or specific requirement (including statutory, regulatory or other citation): Section 200.303 of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), states the following regarding internal control: ?The non-federal entity must: establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statues, regulations, and the terms and conditions of the federal award. These internal controls should be in compliance with guidance in Standards for Internal Control in the Federal Government (also known as the Green Book) issued by the Comptroller General of the United States or the Internal Control ? Integrated Framework (COSO Framework) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).? Kettering Health Schedule of Findings and Questioned Costs (continued) 2307-4310198 73 Section III ? Federal Award Findings and Questioned Costs (continued) Condition: The System did not appropriately design, implement, or retain documentation for internal controls over the PRF Program for the year ended December 31, 2022 to ensure compliance with requirements of the Uniform Guidance. Management also did not retain its documentation over the review and approval of the PRF Program terms and conditions (T&Cs). Cause: Though there are internal controls in place with respect to purchasing and revenue within the System, the System did not specifically have internal controls in place or operating effectively to ensure, or retain documentation to demonstrate compliance, with the PRF Program T&Cs and the Uniform Guidance. Effect or potential effect: If adequate internal controls are not designed, implemented, and documented the System may not be in compliance with the PRF Program T&Cs, or the System may not take necessary actions required to comply with the PRF Program related to all applicable Uniform Guidance compliance requirements. Questioned costs: None. Context: Total federal expenditures for Assistance Listing 93.498 totaled $27,741,256 for the year ended December 31, 2022. Kettering Health Schedule of Findings and Questioned Costs (continued) 2307-4310198 74 Section III ? Federal Award Findings and Questioned Costs (continued) Identification as a repeat finding, if applicable: This is a repeat finding. The prior year finding reference is Finding 2021-003. Recommendation: Due to the nature of this program and the timing of the finding identified in the prior year, the System did not have the opportunity to remediate the prior year finding. While this program likely will not exist in future periods, the System should implement internal controls to document its review and compliance with future federal program T&Cs and the Uniform Guidance and ensure appropriate documentation is retained to support the operating effectiveness of the implemented internal controls. Views of responsible officials: Management agrees with the finding and has developed a plan to address the finding and will ensure appropriate internal controls and documentation are in place for future programs.
Finding 2022-001 ? A. Activities Allowed or Unallowed, B. Allowable Costs / Cost Principles, E. Eligibility, and N. Special Tests and Provisions ? Material Weakness in Internal Controls Over Compliance Identification of the federal program: Assistance Listing 93.461 ? COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured (U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA) (HRSA COVID-19 Uninsured Program) Criteria or specific requirement (including statutory, regulatory or other citation): Section 200.303 of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), states the following regarding internal control: ?The non-federal entity must: establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statues, regulations, and the terms and conditions of the federal award. These internal controls should be in compliance with guidance in Standards for Internal Control in the Federal Government (also known as the Green Book) issued by the Comptroller General of the United States or the Internal Control ? Integrated Framework (COSO Framework) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).? Kettering Health Schedule of Findings and Questioned Costs (continued) 2307-4310198 70 Section III ? Federal Award Findings and Questioned Costs (continued) Health and Human Services (HHS) ? (HRSA issued Terms and Conditions for Participation in the HRSA COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured Program (T&Cs) outlining requirements that recipients of funding from the HRSA COVID-19 Uninsured Program must comply with including the following sections: Testing Services, Treatment Services and Vaccine Administration, and General Provisions in FY2020 Consolidated Appropriations. Condition: The System did not appropriately design or implement internal controls over the HRSA COVID-19 Uninsured Program T&Cs as of and for the year ended December 31, 2022. Cause: Though there are internal controls in place with respect to the System?s revenue cycle, the System did not specifically have internal controls in place to ensure compliance with the HRSA COVID-19 Uninsured Program T&Cs. Effect or potential effect: If adequate internal controls are not designed and implemented, the System may not be in compliance with the HRSA COVID-19 Uninsured Program T&Cs, or the System may not take necessary actions required to comply with the HRSA COVID-19 Uninsured Program related to Uniform Guidance compliance requirements A. Activities Allowed or Unallowed, B. Allowable Costs/Cost Principles, E. Eligibility, and N. Special Tests and Provisions Questioned costs: None. Kettering Health Schedule of Findings and Questioned Costs (continued) 2307-4310198 71 Section III ? Federal Award Findings and Questioned Costs (continued) Context: The HRSA COVID-19 Uninsured Program had federal expenditures of $1,105,658 for the year ended December 31, 2022 and was determined to be Type A major federal program. Identification as a repeat finding, if applicable: This is a repeat finding. The prior year finding reference is Finding 2021-001. Recommendation: Due to the nature of this program and the timing of the finding identified in the prior year, the System did not have the opportunity to remediate the prior year finding. While this program likely will not exist in future periods, the System should implement internal controls to document its review and compliance with future federal program T&Cs and the Uniform Guidance and ensure appropriate documentation is retained to support the operating effectiveness of the implemented internal controls. Views of responsible officials: Management agrees with the finding and has developed a plan to address the finding and will ensure appropriate internal controls and documentation are in place for future programs.
Finding 2022-002 ? A. Activities Allowed or Unallowed and B. Allowable Costs / Cost Principles ? Material Weakness in Internal Controls Over Compliance Identification of the federal program: Assistance Listing 93.498 ? COVID-19 Provider Relief Fund (PRF) and American Rescue Plan (ARP) Rural Distribution (PRF Program) Criteria or specific requirement (including statutory, regulatory or other citation): Section 200.303 of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), states the following regarding internal control: ?The non-federal entity must: establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statues, regulations, and the terms and conditions of the federal award. These internal controls should be in compliance with guidance in Standards for Internal Control in the Federal Government (also known as the Green Book) issued by the Comptroller General of the United States or the Internal Control ? Integrated Framework (COSO Framework) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).? Kettering Health Schedule of Findings and Questioned Costs (continued) 2307-4310198 73 Section III ? Federal Award Findings and Questioned Costs (continued) Condition: The System did not appropriately design, implement, or retain documentation for internal controls over the PRF Program for the year ended December 31, 2022 to ensure compliance with requirements of the Uniform Guidance. Management also did not retain its documentation over the review and approval of the PRF Program terms and conditions (T&Cs). Cause: Though there are internal controls in place with respect to purchasing and revenue within the System, the System did not specifically have internal controls in place or operating effectively to ensure, or retain documentation to demonstrate compliance, with the PRF Program T&Cs and the Uniform Guidance. Effect or potential effect: If adequate internal controls are not designed, implemented, and documented the System may not be in compliance with the PRF Program T&Cs, or the System may not take necessary actions required to comply with the PRF Program related to all applicable Uniform Guidance compliance requirements. Questioned costs: None. Context: Total federal expenditures for Assistance Listing 93.498 totaled $27,741,256 for the year ended December 31, 2022. Kettering Health Schedule of Findings and Questioned Costs (continued) 2307-4310198 74 Section III ? Federal Award Findings and Questioned Costs (continued) Identification as a repeat finding, if applicable: This is a repeat finding. The prior year finding reference is Finding 2021-003. Recommendation: Due to the nature of this program and the timing of the finding identified in the prior year, the System did not have the opportunity to remediate the prior year finding. While this program likely will not exist in future periods, the System should implement internal controls to document its review and compliance with future federal program T&Cs and the Uniform Guidance and ensure appropriate documentation is retained to support the operating effectiveness of the implemented internal controls. Views of responsible officials: Management agrees with the finding and has developed a plan to address the finding and will ensure appropriate internal controls and documentation are in place for future programs.